RATIONALE: Chitinases are enzymes that cleave chitin, a polysaccharide contained in many parasites of humans. Recent studies in mouse models of bronchial asthma have shown that acid mammalian chitinase (AMCase) is involved in the pathophysiology of asthma. It acts downstream of interleukin-13; inhibition of AMCase leads to an abrogated T-helper cell 2 inflammation, less bronchial hyperreactivity, and fewer eosinophils. OBJECTIVES: The aim of this study was to identify common genetic variants in human AMCase and to use them to test for association of AMCase with pediatric asthma. METHODS: By sequencing the promotor region and all 11 exons on 30 individuals, 12 high-frequency polymorphisms were identified. Genotyping of six variants in exons and one promotor polymorphism was performed on the following populations by means of restriction fragment length polymorphisms: 322 children with asthma, 270 randomly chosen adult controls, and a pediatric control population consisting of 565 children who, at age 10 yr, had never wheezed and never been diagnosed having asthma. MEASUREMENTS AND MAIN RESULTS: We identified three known and two new amino acid variants. Analyses by the Armitage's trend test using both control populations showed association of the newly identified variant K17R and the nearby noncoding polymorphism rs3818822 with asthma (p = 0.0031 and p = 0.0003, respectively). In addition, haplotype analyses revealed strong association of haplotypes with the disease (asthma population vs. pediatric control subjects, p < 10(-10)). CONCLUSIONS: This newly described association between AMCase polymorphisms and asthma adds further evidence supporting the involvement of AMCase in the development of asthma.
RATIONALE: Chitinases are enzymes that cleave chitin, a polysaccharide contained in many parasites of humans. Recent studies in mouse models of bronchial asthma have shown that acid mammalian chitinase (AMCase) is involved in the pathophysiology of asthma. It acts downstream of interleukin-13; inhibition of AMCase leads to an abrogated T-helper cell 2 inflammation, less bronchial hyperreactivity, and fewer eosinophils. OBJECTIVES: The aim of this study was to identify common genetic variants in humanAMCase and to use them to test for association of AMCase with pediatric asthma. METHODS: By sequencing the promotor region and all 11 exons on 30 individuals, 12 high-frequency polymorphisms were identified. Genotyping of six variants in exons and one promotor polymorphism was performed on the following populations by means of restriction fragment length polymorphisms: 322 children with asthma, 270 randomly chosen adult controls, and a pediatric control population consisting of 565 children who, at age 10 yr, had never wheezed and never been diagnosed having asthma. MEASUREMENTS AND MAIN RESULTS: We identified three known and two new amino acid variants. Analyses by the Armitage's trend test using both control populations showed association of the newly identified variant K17R and the nearby noncoding polymorphism rs3818822 with asthma (p = 0.0031 and p = 0.0003, respectively). In addition, haplotype analyses revealed strong association of haplotypes with the disease (asthma population vs. pediatric control subjects, p < 10(-10)). CONCLUSIONS: This newly described association between AMCase polymorphisms and asthma adds further evidence supporting the involvement of AMCase in the development of asthma.
Authors: Rolf G Boot; Anton P Bussink; Marri Verhoek; Piet A J de Boer; Antoon F M Moorman; Johannes M F G Aerts Journal: J Histochem Cytochem Date: 2005-05-27 Impact factor: 2.479
Authors: D Defeo-Jones; J Y Tai; G A Vuocolo; R J Wegrzyn; T L Schofield; M W Riemen; A Oliff Journal: Mol Cell Biol Date: 1989-09 Impact factor: 4.272
Authors: Ann Chen Wu; Jessica Lasky-Su; Christine A Rogers; Barbara J Klanderman; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2010-06-10 Impact factor: 21.405
Authors: Steven J Van Dyken; Daniel Garcia; Paul Porter; Xiaozhu Huang; Patricia J Quinlan; Paul D Blanc; David B Corry; Richard M Locksley Journal: J Immunol Date: 2011-08-08 Impact factor: 5.422
Authors: Chun Geun Lee; Carla A Da Silva; Charles S Dela Cruz; Farida Ahangari; Bing Ma; Min-Jong Kang; Chuan-Hua He; Seyedtaghi Takyar; Jack A Elias Journal: Annu Rev Physiol Date: 2011 Impact factor: 19.318
Authors: F Aminuddin; L Akhabir; D Stefanowicz; P D Paré; J E Connett; N R Anthonisen; J V Fahy; M A Seibold; E G Burchard; C Eng; A Gulsvik; P Bakke; M H Cho; A Litonjua; D A Lomas; W H Anderson; T H Beaty; J D Crapo; E K Silverman; A J Sandford Journal: Hum Genet Date: 2011-12-28 Impact factor: 4.132
Authors: Marcus A Mall; Jack R Harkema; Joanna B Trojanek; Diana Treis; Alessandra Livraghi; Susanne Schubert; Zhe Zhou; Silvia M Kreda; Stephen L Tilley; Elizabeth J Hudson; Wanda K O'Neal; Richard C Boucher Journal: Am J Respir Crit Care Med Date: 2007-12-13 Impact factor: 21.405